TCT-251 Abnormal glucose metabolism and adverse event rates 12 months after treatment with contemporary drug-eluting stents: Insights from the BIO-RESORT Silent Diabetes study

Marlies Kok, Clemens von Birgelen, Paolo Zocca, Marc Hartmann, K. Gert van Houwelingen, Martin Stoel, Frits de Man, J. Hans Louwerenburg, Marije Lowik, Gert Kant, Cees Doelman, Gerard C.M. Linssen, Liefke van der Heijden, Carine J.M. Doggen, Kenneth Tandjung

Research output: Contribution to journalMeeting AbstractAcademic

Fingerprint

Dive into the research topics of 'TCT-251 Abnormal glucose metabolism and adverse event rates 12 months after treatment with contemporary drug-eluting stents: Insights from the BIO-RESORT Silent Diabetes study'. Together they form a unique fingerprint.

Medicine & Life Sciences